Alpha 2.0
Login Register
» Articles » PMID: 10492766

Time to Reappearance of Malaria Parasites Following Various Drug Treatment Regimens in a Holoendemic Area of Western Kenya

Overview
Journal Trans R Soc Trop Med Hyg
Publisher Oxford University Press
Specialties Public Health
Tropical Medicine
Date 1999 Sep 24
PMID 10492766
Citations 4
Authors
G D Shanks
B O Ragama
A J Oloo
Affiliations
Soon will be listed here.
Citing Articles

Unanticipated CNS Safety Signal in a Placebo-Controlled, Randomized Trial of Co-Administered Atovaquone-Proguanil and Amodiaquine.

Chalon S, Chughlay M, Abla N, Tchouatieu A, Haouala A, Hutter B Clin Pharmacol Ther. 2021; 111(4):867-877.

PMID: 34453327 PMC: 9291514. DOI: 10.1002/cpt.2404.

Abbreviated atovaquone-proguanil prophylaxis regimens in travellers after leaving malaria-endemic areas: A systematic review.

Savelkoel J, Binnendijk K, Spijker R, van Vugt M, Tan K, Hanscheid T Travel Med Infect Dis. 2017; 21:3-20.

PMID: 29242073 PMC: 10956543. DOI: 10.1016/j.tmaid.2017.12.005.

Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.

Dow G, Magill A, Ohrt C Ther Clin Risk Manag. 2009; 4(4):803-19.

PMID: 19209263 PMC: 2621393. DOI: 10.2147/tcrm.s1025.

Malaria treatment with atovaquone-proguanil in malaria-immune adults: implications for malaria intervention trials and for pre-exposure prophylaxis of malaria.

Polhemus M, Remich S, Ogutu B, Waitumbi J, Lievens M, Ballou W Antimicrob Agents Chemother. 2008; 52(4):1493-5.

PMID: 18268090 PMC: 2292568. DOI: 10.1128/AAC.01367-07.